🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
18 results for “Hikma”
MedicineActive substanceLicence holderStatus
Atracurium 10 mg/ml solution for injection/infusion
PA1217/011/001
Atracurium besilate Hikma Farmacêutica (Portugal) S.A. Not marketed
Ceftazidime 1 g powder for solution for injection/infusion
PA1217/012/002
Ceftazidime Hikma Farmacêutica (Portugal) S.A. Not marketed
Ceftazidime 2 g powder for solution for injection/infusion
PA1217/012/003
Ceftazidime Hikma Farmacêutica (Portugal) S.A. Not marketed
Ceftazidime 500 mg powder for solution for injection
PA1217/012/001
Ceftazidime Hikma Farmacêutica (Portugal) S.A. Not marketed
Imipenem/Cilastatin 500 mg/500 mg powder for solution for infusion
PA1217/005/001
Imipenem monohydrate, Cilastatin sodium Hikma Farmacêutica (Portugal) S.A. Not marketed
Levofloxacin 5 mg/ml solution for infusion
PA1217/008/001
Levofloxacin Hikma Farmacêutica (Portugal) S.A. Not marketed
Levofloxacin 5 mg/ml solution for infusion
PA1217/008/002
Levofloxacin Hikma Farmacêutica (Portugal) S.A. Not marketed
Meropenem 1g powder for solution for injection/infusion
PA1217/006/002
Meropenem Hikma Farmacêutica (Portugal) S.A. Marketed
Meropenem 2 g powder for solution for injection/infusion
PA1217/006/003
Meropenem Trihydrate Hikma Farmacêutica (Portugal) S.A. Not marketed
Meropenem 500 mg powder for solution for injection/infusion
PA1217/006/001
Meropenem Hikma Farmacêutica (Portugal) S.A. Marketed
Teicoplanin Hikma 100 mg powder for solution for injection/infusion
PA1217/010/003
Teicoplanin Hikma Farmacêutica (Portugal) S.A.
Teicoplanin Hikma 200 mg Powder for solution for injection/infusion or oral solution
PA1217/010/001
Teicoplanin Hikma Farmacêutica (Portugal) S.A. Not marketed
Teicoplanin Hikma 400 mg Powder for solution for injection/infusion or oral solution
PA1217/010/002
Teicoplanin Hikma Farmacêutica (Portugal) S.A. Not marketed
Truoxin I.V. 200mg/100ml solution for infusion
PA1217/002/001
Ciprofloxacin Hikma Farmacêutica (Portugal) S.A. Marketed
Truoxin I.V. 400 mg/200 ml solution for infusion
PA1217/002/002
Ciprofloxacin Hikma Farmacêutica (Portugal) S.A. Marketed
Vancomycin 1000 mg Powder for concentrate for solution for infusion
PA1217/009/002
VANCOMYCIN HYDROCHLORIDE Hikma Farmacêutica (Portugal) S.A. Not marketed
Vancomycin 500 mg Powder for concentrate for solution for infusion
PA1217/009/001
VANCOMYCIN HYDROCHLORIDE Hikma Farmacêutica (Portugal) S.A. Not marketed
Voriconazole Hikma 200 mg powder for solution for infusion
EU/1/15/1004/001-002
Voriconazole Hikma Farmacêutica (Portugal) S.A.
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.